Daniela Opriș-Belinski

Mapping and predicting mortality from systemic sclerosis

Muriel Elhaï, Christophe Meune, Marouane Boubaya et al. · Annals of the Rheumatic Diseases · 2017 · 684 citations · Full text

Public Health, Biostatistics, Clinical Epidemiology +16

Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial

Atul Deodhar, Désirée van der Heijde, Lianne S. Gensler et al. · The Lancet · 2019 · 214 citations

Medicine, Clinical Sciences, Pharmacotherapy +10

Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study

Atul Deodhar, Alice B. Gottlieb, Wolf‐­Henning Boehncke et al. · The Lancet · 2018 · 184 citations

Medicine, Clinical Sciences, Pharmacotherapy +7

“To Be or Not To Be,” Ten Years After: Evidence for Mixed Connective Tissue Disease as a Distinct Entity

Susanna Cappelli, Silvia Bellando-Randone, Dušanka Martinović et al. · Seminars in Arthritis and Rheumatism · 2012 · 161 citations

Medicine, Internal Medicine, Pathology +11

Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial

Maarten Boers, Linda Hartman, Daniela Opriș-Belinski et al. · Annals of the Rheumatic Diseases · 2022 · 161 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +17